First Solar, Inc.
FSLR - NASDAQ - $219.95 ▲ +%2.51
-
Earnings Thu 30 Jul

First opens the
books on Thursday evening.

9 analysts' median target is $245[FMP target], stock is $220, +11.4% upside potential. After Q1 +12.2% EPS beat[FMP earnings], the stock moved +4.9%.

summary below
Quick Take - in 40 seconds
A-
HOLD Council 3/6 - Moonshot 39

A- = MoonshotScore 39[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $1.1B[FMP est], EPS $3.26[FMP est]. 1 consecutive quarters of beat[FMP earnings].

$3.26 EPS Estimate Last year $4.84 - +3% YoY YoY
1 Beat Streak Expectations beaten consecutively for the last 1 quarters

Q1 EPS +12.2% beat[FMP] but the stock +4.9% D+1[FMP D+1]. Alexander Bradley promised $118.5M CapEx + a sequential decline in Q4 during the Q1 earnings call[Alexander Bradley capex transcript].

Watchlist

6 metrics stand out this quarter.

6 Investor Focus

CuRe Revenue Potential

CuRe_Revenue_Potential

Replication of CuRe across the Series 6 and 7 fleet supports the potentialization of up to $0.6 billion of additional revenue from technology adjusters, with the majority anticipated in 2027 and 2028.

"CuRe is scheduled to be replicated across the Series 6 and 7 fleet through the first half of 2028, which, if achieved, supports the potentialization of up to $0.6 billion of additional revenue from technology adjusters in the backlog with the majority anticipated in 2027 and 2028."

- Mark Widmar, CEO - Q1 FY26 Earnings Call - April 30, 2026
2026 Expectation / Guide

FY26 Guidance Reaffirmation

FY26_Guidance_Reaffirmation

First Solar's full year 2026 guidance remains unchanged, reflecting confidence in the company's strategy and performance.

"Our full year 2026 guidance remains unchanged."

- Alexander Bradley, CFO - Q1 FY26 Earnings Call - April 30, 2026
2026 Investor Focus

South Carolina Finishing Facility

South_Carolina_Finishing_Facility

First Solar's South Carolina finishing facility is on track for production start in the second half of 2026, expected to provide finishing capacity for Series 6 modules.

"South Carolina finishing facility is on track for production start in the second half of 2026, with equipment installation beginning this quarter. Upon completion, this facility is expected to provide finishing capacity for Series 6 modules initiated at our international factories and optimize freight, tariff and domestic content outcomes while benefiting from Section 45X module assembly tax credits."

- Mark Widmar, CEO - Q1 FY26 Earnings Call - April 30, 2026
31 Investor Focus

Backlog And ASP

Backlog_and_ASP

As of March 31, 2026, First Solar's contracted backlog was 47.9 gigawatts at an aggregate transaction price of $14.4 billion, exclusive of technology adjusters with deliveries through 2030.

"As of March 31, 2026, our contracted backlog was 47.9 gigawatts at an aggregate transaction price of $14.4 billion, exclusive of technology adjusters with deliveries through 2030."

- Alexander Bradley, CFO - Q1 FY26 Earnings Call - April 30, 2026
8% Investor Focus

CuRe Technology Advantage

CuRe_Technology_Advantage

CuRe technology is expected to deliver up to 8% more lifetime specific energy yield than crystalline silicon Topcon, providing a competitive advantage for First Solar.

"With CuRe anticipated to deliver up to 8% more lifetime specific energy yield than crystalline silicon Topcon."

- Mark Widmar, CEO - Q1 FY26 Earnings Call - April 30, 2026
96% Investor Focus

US Manufacturing Utilization

US_Manufacturing_Utilization

First Solar's U.S. facilities operated at approximately 96% utilization in the quarter, demonstrating strong manufacturing performance.

"Our U.S. facilities operated at approximately 96% utilization."

- Mark Widmar, CEO - Q1 FY26 Earnings Call - April 30, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 3 / 6 Bullish

6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +11.4%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 64
Klarman value - target upside +11.4%
Buffett quality - ROE score 5/5
Munger valuation - target upside +11.4%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthStrong
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
64.1 RSI 64.1 positive momentum, 50d above
MACD
+11.20 price above 50d - support positive
50d MA
$198 stock 11.2% above - short-term support
200d MA
$223 stock 1.3% below - long-term pressure
Volume (10d)
-29% decrease - low participation
Resistance
$245
Analyst median target - upgrade trigger if broken
Current
$220
Pre-earnings position
Support
$189
Invalidation - close below this is a technical breakdown
Pattern
Range
$189-$245 band - earnings breakout/breakdown trigger

Past Performance

First's last 8 quarters: 1 consecutive beats.

BEAT
Q2 FY25
$3.18 vs $2.66 est - +5.3%
MISS
Q3 FY25
$4.24 vs $4.24 est - +14.3%
MISS
Q4 FY25
$4.84 vs $5.14 est - -13.6%
BEAT
Q1 FY26
$3.22 vs $2.87 est - +4.9%

Q1 (April 30, 2026): EPS $3.22 vs $2.87 est[FMP], +12.2% beat. D+1 movement: +4.9%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $3.16 (no guidance)

Q1: EPS $3.22 vs $2.87 beat[FMP], stock +4.9% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $118.5M[FMP cashflow]. Q1 op margin 33.8%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $3.26 + CapEx discipline
Threshold: EPS > $3.26[FMP est].
Target: Break above median target $245[FMP target]; high target $326[FMP] upper bound.
Scenario B - In-Line
EPS approx $3.26 + CapEx < $118.5M
Threshold: EPS approx $3.26[FMP est], Q4 CapEx < $118.5M[FMP].
Target: Consolidation in the band between current $220[FMP] and median $245[FMP].
Scenario C - Miss
EPS < $3.16 or CapEx >= $118.5M
Threshold: EPS < $3.16[FMP estx0.97].
Target: Current $220 below SMA200 $223[FMP], if rejection continues, $189[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 9 analysts say?

Wall Street Consensus
$245
12-month median target price (+11.4% upside potential)
21
BUY
14
HOLD
1
SELL
Risk Management
$189
Invalidation level - critical support threshold
$198 - 50-day MA (above, +11.2%)
$223 - 200-day MA (below, -1.3%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - FSLR Q4 FY26
A-

You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Thursday evening. The framework is ready on this page: Q4 EPS threshold $3.26[FMP], CapEx threshold "below $118.5M"[Alexander Bradley]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 30, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jul 31, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 13, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Oct 30, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the FSLR earnings preview cover?

This FSLR (FSLR) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in FSLR earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.